A pathogenic GGGCCC hexanucleotide expansion in the first intron/promoter region of the C9orf72 gene is the most common mutation associated with both ALS (∼11% of all cases) and FTLD/FTD (∼13%) [3–6]. This evidence concerns the gene C9orf72 and amyotrophic lateral sclerosis.